Literature DB >> 3875726

11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).

S Stone-Elander, M Ingvar, P Johnström, E Ehrin, B Garmelius, T Greitz, J L Nilsson, B Resul, M L Smith, L Widén.   

Abstract

Radiolabeled 4-isopropylantipyrine (1) has been synthesized and evaluated as a tracer for the measurement of cerebral blood flow (CBF). Methylation of 4-isopropyl-3-methyl-1-phenylpyrazol-5-one (2) with [14C]methyl iodide in acetonitrile gave [14C]-1 in radiochemical yields of 10-20%. Its blood-brain partition coefficient in rats was determined to be 0.62 +/- 0.03 (mean +/- SE). Autoradiographic determination of regional cerebral blood flow under normal flow conditions indicated that [14 C]-1 gives results essentially identical with those obtained with the widely used tracer [14C]-4-iodoantipyrine ( [14C]-IAP). Studies performed in high-flow states indicated that [14C]-1 is not more diffusion limited than [14C]-IAP. A rapid synthesis was therefore developed for the preparation of [11C]-1. Radiochemical yields were increased to 40-50% when the alkylation of 2 with [11C]methyl iodide was performed in dimethyl sulfoxide using solid potassium hydroxide as a base. Since the 11C-labeled compound can easily be produced in large quantities and since the tracer is not diffusion limited at flow rates commonly observed in normal and most pathological states in man, [11C]-4-isopropylantipyrine will be used for in vivo studies of CBF using positron emission tomography.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875726     DOI: 10.1021/jm00147a036

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  1 in total

1.  The preparation of 11C-labelled fluoromethane for the study of regional cerebral blood flow using positron emission tomography.

Authors:  S Stone-Elander; P Roland; L Eriksson; J E Litton; P Johnström; L Widén
Journal:  Eur J Nucl Med       Date:  1986
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.